Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Patient fibroblast circadian rhythms predict lithium sensitivity in bipolar disorder.

Sanghani HR. et al, (2020), Mol Psychiatry

The True Colours Remote Symptom Monitoring System: A Decade of Evolution.

Goodday SM. et al, (2020), J Med Internet Res, 22

A web-based clinical decision tool to support treatment decision-making in psychiatry: a pilot focus group study with clinicians, patients and carers.

Henshall C. et al, (2017), BMC Psychiatry, 17

A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development.

Cipriani A. et al, (2016), Mol Psychiatry, 21, 1324 - 1332

Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial.

Saunders KEA. et al, (2016), Trials, 17

Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial.

Geddes JR. et al, (2016), Lancet Psychiatry, 3, 31 - 39

Does drug treatment reduce the risk of further self-harm or suicide?: Commentary on… cochrane corner

Smith K. and Attenburrow MJ., (2016), BJPsych Advances, 22, 3 - 7

Ketamine: A novel antidepressant with a fast onset of action?:Commentary on… cochrane corner

Smith K. and Attenburrow MJ., (2016), BJ Psych Advances, 22, 216 - 221

Comparative evaluation of quetiapine plus lamotrigine versus quetiapine monotherapy in people with bipolar depression: a randomized trial (CEQUEL)

Geddes JR. et al, (2015), BIPOLAR DISORDERS, 17, 50 - 51

Internet-delivered therapy for anxiety disorders: A solution to unequal access to treatment?: Commentary on... Cochrane Corner

Attenburrow MJ. and Smith K., (2015), BJ Psych Advances, 21, 291 - 294

Sleep problems in Alzheimer's disease: Does drug treatment help or harm?: COMMENTARY ON... COCHRANE CORNER

Smith K. and Attenburrow MJ., (2015), BJ Psych Advances, 21, 219 - 221

Valproate? Lithium comes first: Commentary on⋯ cochrane corner

Attenburrow MJ. and Smith K., (2015), BJ Psych Advances, 21, 3 - 4

Revealing the mind's eye: bringing (mental) images into psychiatry.

Di Simplicio M. et al, (2012), Am J Psychiatry, 169, 1245 - 1246

Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients.

Sharpley AL. et al, (2005), J Clin Psychiatry, 66, 450 - 454

Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.

Nadeem HS. et al, (2004), Neuropsychopharmacology, 29, 1699 - 1703

Olanzapine increases slow wave sleep in SSRI resistant depressed patients

Sharpley AL. et al, (2004), JOURNAL OF PSYCHOPHARMACOLOGY, 18, A14 - A14

Assessment and treatment of insomnia (including a case control study of patients with Primary Insomnia).

Sharpley AL. et al, (1997), Int J Psychiatry Clin Pract, 1, 107 - 117

Low dose melatonin improves sleep in healthy middle-aged subjects.

Attenburrow ME. et al, (1996), Psychopharmacology (Berl), 126, 179 - 181

The effects of paroxetine and nefazodone on sleep: a placebo controlled trial.

Sharpley AL. et al, (1996), Psychopharmacology (Berl), 126, 50 - 54

Case-control study of evening melatonin concentration in primary insomnia.

Attenburrow ME. et al, (1996), BMJ, 312, 1263 - 1264

Load More

Include forthcoming?